Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) Research & Development (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Research & Development for 13 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development fell 45.68% year-over-year to $2.5 million, compared with a TTM value of $15.0 million through Sep 2025, down 15.2%, and an annual FY2024 reading of $18.0 million, up 10.36% over the prior year.
  • Research & Development was $2.5 million for Q3 2025 at Aspen Aerogels, down from $3.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $4.7 million in Q3 2022 and bottomed at $2.4 million in Q1 2021.
  • Average Research & Development over 5 years is $3.9 million, with a median of $4.1 million recorded in 2023.
  • The sharpest move saw Research & Development skyrocketed 70.45% in 2022, then tumbled 45.68% in 2025.
  • Year by year, Research & Development stood at $3.3 million in 2021, then increased by 26.68% to $4.2 million in 2022, then dropped by 2.91% to $4.1 million in 2023, then increased by 8.1% to $4.4 million in 2024, then tumbled by 43.38% to $2.5 million in 2025.
  • Business Quant data shows Research & Development for ASPN at $2.5 million in Q3 2025, $3.8 million in Q2 2025, and $4.3 million in Q1 2025.